Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Phosphorus or phosphorus compound
Patent
1995-04-05
1998-03-31
Weddington, Kevin E.
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Phosphorus or phosphorus compound
424610, 424663, 424717, 514 23, 514867, A61K 3342, A61K 3170
Patent
active
057335796
ABSTRACT:
An oral rehydration solution contains indigestible oligosaccharides. Diarrhea related dehydration requires fluid and electrolyte replacement. The primary etiology of antibiotic-associated diarrhea (also known as pseudomembranous colitis) has been recognized as Clostridium difficile. It is believed that the indigenous microflora of a healthy individual suppresses the normally present C. difficile. However, when the indigenous microflora are disrupted (e.g., during antibiotic treatment) overgrowth of C. difficile may occur causing diarrhea and colitis. Treatment of diarrhea related to C. difficile with rehydration therapy and antibiotics has proven effective, but many times relapse occurs. It has been suggested that normalization of the microflora will inhibit C. difficile relapse. Indigestible oligosaccharides have been shown to inhibit C. difficile infection.
REFERENCES:
patent: 4312856 (1982-01-01), Korduner et al.
patent: 4681771 (1987-07-01), Adachi et al.
patent: 5164192 (1992-11-01), Louwes
patent: 5397786 (1995-03-01), Simone
Bryant et al., Journal of Dairy Science, 36:205-217 (1953).
Gill et al., Journal of Animal Sciences, 33:331-336 (1971).
Neter & Wasserman, Applied Linear Statistical Models, Richard D. Irwin, Inc., (1974), pp. 329-335.
Lusk et al., The Journal of Infectious Diseases, 137(4):464-475 (1978).
Mulligan et al., Current Microbiology, 3:173-175 (1979).
George et al., Journal of Clinical Microbiology, 9(2):214-219 (1979).
Bartlett et al., Gastroenterology, 78:431-434 (1980).
Banno et al., Biochemistry International, 2(6):625-635 (1981).
Taylor et al., Infection and Immunity, 34:1036-1043 (1981).
Casparey et al., Clinical Research Review, 1(Suppl. 1):107-177 (1981).
Wilson et al., Infection and Immunity, 34(2):626-628 (1981).
Sullivan et al., Infection and Immunity, 35(3):1032-1040 (1982).
Walters et al., Gut, 24:206-212 (1983).
Pocock, Clinical Trials: A Practical Approach, John Wiley & Sons Ltd., (1983), pp. 10-13 and 222-225.
Wilson et al., The Journal of Infectious Diseases, 151(2):355-361 (1985).
Bender et al., The Lancet, 2:11-13 (1986).
Wilson et al., The Journal of Infectious Diseases, 153(3):547-551 (1986).
Rosner, Fundamentals of Statistics, PWS Publishers, (1986), pp. 286-292.
Meyer et al., Applied and Environmental Microbiology, 51(3):622-629 (1986).
Triadafilopoulos et al., Gastroenterology, 93:273-279 (1987).
Mackie et al., Applied and Environmental Microbiology, 54(9):2155-2160 (1988).
McFarland et al., The New England Journal of Medicine, 320(4):204-210 (1989).
Fekety et al., The American Journal of Medicine, 86:15-19 (1989).
Thomas et al., Journal of the American Geriatrics Society, 38:415-420 (1990).
Brown et al., Infection Control Hospital Epidemiology, 11(6):283-290 (1990).
McFarland et al., The Journal of Infectious Diseases, 162:678-684 (1990).
Kimmey et al., Digestive Diseases and Sciences, 35(7):897-901 (1990).
Johnson et al., Annals of Internal Medicine, 117(4):297-302 (1990).
Okazaki et al., Bifidobacteria Microflora, 9(2):77-86 (1990).
Imaizumi et al., Agricultural and Biological Chemistry, 55(1):199-205 (1991).
Kofsky et al., Diseases of the Colon and Rectum, 34:244-248 (1991).
Fekety, Diarrheal. Diseases, ed by M. Field, Elsevier (1991), pp. 293-317.
Hidaka et al., Journal of Carbohydrate Chemistry, 10(4):509-522 (1991).
Bennett et al., Geriatrics, 45(9):77-87 (1990).
Fekety et al., Journal of the American Medical Association, 269(1) 71-75 (1993).
Ramakrishna, Gut, 34:1215-1218 (1993).
Bowling et al., Gut, 34(Suppl. 1):A54 (1993).
Bowling et al., Clinical Nutrition, 12(Suppl. 2):23 (1993).
Bowling et al., The Lancet, 342:1266-1268 (1993).
Warren et al., American Journal of Public Health 84(8):1265-1269 (1994).
McFarland et al., Journal of the American Medical Association, 271(4):1913-1918 (1994).
Kelly et al., The New England Journal of Medicine, 330(4):257-262 (1994).
Campbell Sheila Martinson
Garleb Keith Allen
Meulbroek Jonathan Allan
Walton Joseph Edward
Wheeler Keith Brian
Abbott Laboratories
Brainard Thomas D.
Drayer Lonnie
Nickey Donald O.
Weddington Kevin E.
LandOfFree
Oral rehydration solution containing indigestible oligosaccharid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oral rehydration solution containing indigestible oligosaccharid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral rehydration solution containing indigestible oligosaccharid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-49434